Xylem Inc.
XYL
$143.74
$3.522.51%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 6.09% | 1.77% | 6.52% | 1.35% | 25.96% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 6.09% | 1.77% | 6.52% | 1.35% | 25.96% |
Cost of Revenue | 4.37% | 1.56% | 2.72% | 0.61% | 26.05% |
Gross Profit | 8.91% | 2.13% | 13.36% | 2.62% | 25.81% |
SG&A Expenses | 3.70% | -2.95% | 37.46% | -9.55% | 8.97% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 4.07% | 0.17% | 9.07% | -2.41% | 20.25% |
Operating Income | 20.00% | 15.14% | -5.75% | 34.60% | 87.07% |
Income Before Tax | 21.05% | 10.71% | 78.57% | 45.41% | 116.67% |
Income Tax Expenses | 41.51% | 16.28% | 187.50% | 57.58% | 140.91% |
Earnings from Continuing Operations | 15.46% | 9.15% | 22.56% | 42.76% | 110.87% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 16.49% | 10.46% | 22.56% | 42.76% | 110.87% |
EBIT | 20.00% | 15.14% | -5.75% | 34.60% | 87.07% |
EBITDA | 13.10% | 12.50% | -3.19% | 18.72% | 75.73% |
EPS Basic | 16.11% | 9.90% | 21.69% | 41.57% | 78.66% |
Normalized Basic EPS | 21.60% | 18.43% | -7.80% | 32.37% | 60.49% |
EPS Diluted | 16.11% | 9.52% | 21.05% | 41.27% | 78.66% |
Normalized Diluted EPS | 21.80% | 18.69% | -7.64% | 32.64% | 60.84% |
Average Basic Shares Outstanding | 0.33% | 0.52% | 0.72% | 0.86% | 18.03% |
Average Diluted Shares Outstanding | 0.16% | 0.31% | 0.54% | 0.64% | 17.78% |
Dividend Per Share | 11.11% | 11.11% | 9.09% | 9.09% | 9.09% |
Payout Ratio | -0.03% | 0.01% | -0.11% | -0.23% | -0.48% |